Profile data is unavailable for this security.
About the company
Cosmos Health Inc. is a global healthcare company. The Company owns a portfolio of pharmaceutical and nutraceutical brands, including Sky Premium Life, Mediterranation, bio-bebe and C-Sept. Through its subsidiary, Cana Laboratories S.A., it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. It distributes a line of pharmaceuticals and Para pharmaceuticals, including branded generics and over the counter (OTC) medications, to retail pharmacies and wholesale distributors through its subsidiaries in Greece and the United Kingdom. It is also engaged in the research and development (R&D) of patented nutraceuticals and specialized root extracts as well as in the R&D of complex generics and OTC products. It offers Cloudscreen, a multimodal platform specialized in drug repurposing, a process of uncovering new target proteins. It is also specialized in the storage and distribution of pharmaceutical and Para pharmaceutical goods.
- Revenue in USD (TTM)49.59m
- Net income in USD-42.91m
- Incorporated2009
- Employees102.00
- LocationCosmos Health Inc141 W. JACKSON BLVD, SUITE 4236CHICAGO 60604United StatesUSA
- Phone+1 (312) 536-3102
- Websitehttps://www.cosmosholdingsinc.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Global Technologies Ltd | 454.51k | 36.30k | 4.41m | -- | -- | -- | 89.07 | 9.70 | 0.00 | 0.00 | 0.00003 | 0.00008 | 0.1066 | -- | 6.90 | -- | 0.8516 | -- | -- | -- | 19.87 | -- | 7.99 | -- | -- | -- | 0.3005 | -- | -86.35 | -- | 19.11 | -- | -- | -- |
| Zeo Scientifix Inc | 4.64m | -5.74m | 5.82m | 23.00 | -- | -- | -- | 1.25 | -0.8249 | -0.8249 | 0.6729 | -0.2462 | 1.38 | 1.88 | 30.66 | 201,828.30 | -170.08 | -371.43 | -- | -- | 87.89 | 88.28 | -123.65 | -200.71 | 0.4017 | -14.47 | -- | -- | -29.78 | 36.43 | 21.47 | -- | 40.91 | -- |
| Cosmos Health Inc | 49.59m | -42.91m | 11.68m | 102.00 | -- | 0.2026 | -- | 0.2355 | -7.92 | -7.92 | 5.07 | 3.43 | 0.8466 | 9.26 | 1.78 | 486,159.40 | -26.65 | -18.81 | -54.15 | -75.34 | 7.17 | 11.90 | -31.48 | -13.96 | 1.79 | -16.85 | 0.1831 | -- | -10.48 | 10.90 | -310.05 | -- | 47.25 | -- |
| Bio Essence Corp | 551.51k | -802.55k | 12.92m | 12.00 | -- | -- | -- | 23.43 | -0.0223 | -0.027 | 0.0156 | -0.0437 | 0.262 | 1.69 | 27.11 | 45,959.17 | -38.13 | -46.34 | -- | -- | 50.31 | 33.89 | -145.52 | -111.21 | 0.3017 | -45.50 | 5.31 | -- | -11.27 | -10.94 | -52.03 | -- | -48.19 | -- |
| BIMI Holdings Inc | 12.63m | -10.52m | 16.05m | 296.00 | 0.7992 | 0.8813 | -- | 1.27 | 1.44 | 1.59 | 2.63 | 1.30 | 0.3713 | 1.81 | 2.25 | 42,677.87 | -31.04 | -38.59 | -77.82 | -88.93 | 40.30 | 34.59 | -83.60 | -135.61 | 0.8572 | -24.66 | 0.1134 | -- | -44.51 | 6.82 | 37.56 | -- | -- | -- |
| Exceed World Inc | 22.96m | -1.33m | 21.12m | 41.00 | -- | 1.33 | -- | 0.9202 | -0.0405 | -0.0405 | 0.702 | 0.4873 | 0.8953 | 10.42 | 424.59 | 559,890.50 | -5.17 | 4.14 | -7.27 | 6.17 | 50.19 | 48.99 | -5.77 | 4.02 | 3.01 | -622.74 | 0.0019 | -- | -25.27 | -5.76 | -113.33 | -- | -31.13 | -- |
| Microalliance Group Inc | 22.88m | 9.82m | 36.62m | 30.00 | 4.44 | 1.20 | 3.68 | 1.60 | 0.0135 | 0.0135 | 0.0325 | 0.0501 | 0.7631 | 0.4869 | 12.65 | 762,790.30 | 32.74 | -- | 35.89 | -- | 68.46 | -- | 42.90 | -- | 12.67 | -- | 0.00 | -- | 3,030.68 | -- | 3,074.43 | -- | -- | -- |
| Able View Global Inc | 149.00m | 9.44m | 46.90m | 98.00 | 5.02 | 4.16 | 4.85 | 0.3148 | 0.2229 | 0.2229 | 3.52 | 0.2695 | 2.72 | 6.20 | 8.37 | 1,520,406.00 | 17.80 | -- | 30.88 | -- | 24.84 | -- | 6.54 | -- | 1.99 | 7.90 | 0.2017 | -- | 2.58 | -- | 23.46 | -- | -- | -- |
| Holder | Shares | % Held |
|---|---|---|
| BlackRock Fund Advisorsas of 31 Mar 2024 | 288.34k | 1.70% |
| The Vanguard Group, Inc.as of 31 Mar 2024 | 134.83k | 0.80% |
| Geode Capital Management LLCas of 31 Mar 2024 | 103.32k | 0.61% |
| SSgA Funds Management, Inc.as of 31 Mar 2024 | 24.74k | 0.15% |
| Northern Trust Investments, Inc.(Investment Management)as of 31 Mar 2024 | 20.55k | 0.12% |
| HRT Financial LLCas of 31 Mar 2024 | 11.77k | 0.07% |
| Group One Trading LPas of 31 Mar 2024 | 9.88k | 0.06% |
| Tower Research Capital LLCas of 31 Mar 2024 | 4.81k | 0.03% |
| Simplex Trading LLCas of 31 Mar 2024 | 3.35k | 0.02% |
| BlackRock Investment Management LLCas of 31 Mar 2024 | 2.73k | 0.02% |
